FBB Biomed

Coralville, United States Founded: 2020 • Age: 6 yrs
In-vitro diagnostic tests for COVID-19 and neurological diseases are developed.

About FBB Biomed

FBB Biomed is a Healthcare company based in Coralville (United States) founded in 2020. In-vitro diagnostic tests for COVID-19 and neurological diseases are developed. FBB Biomed has raised $401 thousand across 2 funding rounds. Its chief executive, as recorded, is Howard Urnovitz. FBB Biomed offers products and services including FBB Test and Research Blood Tests. Its focus areas include Life Sciences, Neurology, In-Vitro Diagnostics and Neurodevelopmental Disorders. Its legal entity is FBB Biomed, Inc. Its competitors include DermTech, NeuMoDx and Kryptos Biotechnologies; 3 of its 3 listed competitors have raised funding.

Company details

FBB Biomed was founded in 2020 and is based in Coralville, United States, within the biotechnology sector focused on diagnostics. In-vitro tests for COVID-19 and neurological conditions are developed through a process where finger-stick blood samples are collected from patients, RNA is extracted, and analysis is conducted via qPCR. Clinical reports are then produced and interpreted. Data from blood samples of three relapsing-remitting multiple sclerosis patients have been incorporated.

Key Metrics
  • Total Equity Funding
    $401K (USD)

    in 2 rounds

  • Latest Funding Round
    $326K (USD), Seed

    Aug 2020

Products & Services of FBB Biomed

FBB Biomed offers a comprehensive portfolio of products and services, including FBB Test and Research Blood Tests.

FBB Test
Blood Testing

Noninvasive test to detect genes linked to autoimmune diseases for research.

Research Blood Tests
Diagnostic Tools

Tools for measuring external influences on neurologic health in studies.

Apps and channels of FBB Biomed

its YouTube channel FBB Biomed has 53 subscribers and 27 videos.

FBB Biomed
YouTube 53 subscribers 27 videos Science & Technology
Open channel

Videos from FBB Biomed

The most watched videos on FBB Biomed's YouTube channel, FBB Biomed (53 subscribers). Click a video to play it here.

Patent Filed for One Life, One Test: The Journey of FBB Biomed's 2023 Innovator of the Year Award
816 views
FBB Product Demonstration - Blood Test for Brain Diseases
580 views
Patent Filed. Disease Clarity Achieved. Actionable Biomarkers and Treatment. Let’s Talk Licensing.
567 views
Welcome to The Golden Age of Virology: A New Era in Medical Research
378 views

More on FBB Biomed.

Funding Insights of FBB Biomed

FBB Biomed has successfully raised a total of $401K across 2 strategic funding rounds. The most recent funding activity was a Seed round of $326 thousand completed in August 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $401,000
  • Total Rounds 2
  • Last Round Seed β€” $326,000
  • First Round $75,000

    (Jan 2020)

All 2 funding rounds of FBB Biomed with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Aug 2020$326,000Seed––
–
Jan 2020$75,000Seed––
–

People of FBB Biomed

9 people are tracked at FBB Biomed (2 in leadership, 7 in team).

NameRoleGroup
Howard Urnovitz
CEOLeadership
Steven Urnovitz
Co-founder, COOLeadership
Heinz Haenel
Product GTM ExpertTeam
Shauna Turner
Biotech Industry ExpertTeam
Lior Nuchi
Tech Industry LawyerTeam
Timothy Dodd
Insurance Industry ExpertTeam
Heinz Dr. Hänel
Senior BeraterTeam
Michael S. Chimenti
Machine Learning & Bioinformatics ConsultantTeam
Lindsey Kaschmitter
Research AnalystTeam
Premium access

Complete people profiles for FBB Biomed

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of FBB Biomed

3 dated milestones of FBB Biomed, from founding to its latest funding, stage changes and deals.

  1. Founded FBB Biomed is founded.
  2. Funding First funding round of $75K.
  3. Funding Latest funding round, Seed, of $326K.

Competitors of FBB Biomed

FBB Biomed has 3 listed competitors in our database, 3 of them funded. They include DermTech, NeuMoDx and Kryptos Biotechnologies.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
dermtech.com1996San Diego, United States$24.37M259
Adhesive patch biopsies for skin cancer detection are provided.
neumodx.com2012Ann Arbor, United States$66.04M125
Developer of a platform for low cost molecular testing
kryptosbio.com2017Hayward, United States$12.7M
Point-of-care molecular diagnostics are enabled by Ultrafast Photonic PCR technology.
Premium access

Detailed competitors of FBB Biomed

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Genomics & Gene Therapy Platforms

3 companies that operate in the same segment as FBB Biomed (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
mRNA-based therapeutics for diseases including cancer and infections are developed.
2010Cambridge, Massachusetts, United StatesUSD 2.78 BUSD 1.94 B5,800
Digital sequencing technology for cancer detection is developed.
2012Redwood City, California, United StatesUSD 557.5 MUSD 982.02 M4,867
Circulating tumor DNA is screened for early cancer detection.
2016Menlo Park, California, United StatesUSD 2 BUSD 147.17 M1,141
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Fbb Biomed

Premium access

Complete news archive for FBB Biomed

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about FBB Biomed

FBB Biomed was founded in 2020.

FBB Biomed is headquartered in Coralville, United States. It is registered at Coralville, Iowa, United States.

Howard Urnovitz is the CEO of FBB Biomed, as recorded in our data.

FBB Biomed is a funded company, having raised a total of $401K across 2 funding rounds to date. The company's 1st funding round was a Seed of $75K, raised on Jan 2020.

FBB Biomed was founded in 2020 and is based in Coralville, United States, within the biotechnology sector focused on diagnostics. In-vitro tests for COVID-19 and neurological conditions are developed through a process where finger-stick blood samples are collected from patients, RNA is extracted, and analysis is conducted via qPCR. Clinical reports are then produced and interpreted. Data from blood samples of three relapsing-remitting multiple sclerosis patients have been incorporated.

FBB Biomed's top competitors include DermTech, NeuMoDx and Kryptos Biotechnologies.

FBB Biomed offers FBB Test and Research Blood Tests.

FBB Biomed operates through Fbb Biomed, Inc..

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available